Awareness and clinical management of metabolic dysfunction-associated steatotic liver disease among physicians in Milan: a cross-sectional survey
Digestive and Liver Disease · 2026-11
DOI: 10.1016/j.dld.2026.10.023 ↗Kurz gefasst
Leserbrief in der Zeitschrift Digestive and Liver Disease, 2026-11. Verfasst von Jessica Rondena und 3 weiteren Autor:innen. Beteiligte Einrichtung: Precision Medicine Lab, Biological Resource Center and Department of Transfusion Medicine, Fondazione IRCCS ca' Granda Ospedale Maggiore Policlinico …. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Government Ministry of Health.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) is defined within the new steatotic liver disease nomenclature and requires assessment of cardiometabolic risk factors, with increasing emphasis on appropriate non-invasive assessment of liver fibrosis [1]. The transition from the previous NAFLD terminology to MASLD within the broader steatotic liver disease (SLD) umbrella, the validation of clinical referral pathways and the approval of the new pharmaceutical approaches to treat MASLD associated with liver fibrosis represent major advances and important changes in clinical practice and may require specific educational efforts across different medical settings.
Autor:innen und Institutionen
- Precision Medicine Lab, Biological Resource Center and Department of Transfusion Medicine, Fondazione IRCCS ca' Granda Ospedale Maggiore Policlinico Milano, Milan, 20122, Italy; Department of Pathophysiology and Transpl…
- S.C. Medicine - Haemostasis and Thrombosis, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, 20122, Italy; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, 201…
- Ordine dei Medici Chirurghi e degli Odontoiatri di Milano, Milan, 20123, Italy.
- Precision Medicine Lab, Biological Resource Center and Department of Transfusion Medicine, Fondazione IRCCS ca' Granda Ospedale Maggiore Policlinico Milano, Milan, 20122, Italy; Omic Sciences Lab, Scientific Direction,…
Förderung
- Italian Government Ministry of Health
Zitieren
APA
Rondena, J., Gualtierotti, R., Rossi, R. C., & Valenti, L. (2026). Awareness and clinical management of metabolic dysfunction-associated steatotic liver disease among physicians in Milan: a cross-sectional survey. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2026.10.023
Vancouver
Rondena J, Gualtierotti R, Rossi RC, Valenti L. Awareness and clinical management of metabolic dysfunction-associated steatotic liver disease among physicians in Milan: a cross-sectional survey. Digestive and Liver Disease. 2026. doi:10.1016/j.dld.2026.10.023
BibTeX
@article{Rondena2026,
author = {Rondena, Jessica and Gualtierotti, Roberta and Rossi, Roberto Carlo and Valenti, Luca},
title = {Awareness and clinical management of metabolic dysfunction-associated steatotic liver disease among physicians in Milan: a cross-sectional survey},
journal = {Digestive and Liver Disease},
year = {2026},
doi = {10.1016/j.dld.2026.10.023}
}
EUVIMED